Incidence of rash and discontinuation of nevirapine using two different escalating initial doses

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026

Trehalose Exerts Selective Cytotoxicity Against Tongue Squamous Cell Carcinoma Cells While Exhibiting Limited Cytotoxicity Toward Normal Oral Squamous Cells.

OncoTargets and therapy·2026

Pathological Complete Response following Pembrolizumab Combined with Gemcitabine and Cisplatin Therapy for Initially Unresectable Intrahepatic Cholangiocarcinoma: A Case Report.

Case reports in oncology·2026

Anti-angiogenic therapy in thymic carcinoma: a narrative review of current evidence and emerging combinations.

Mediastinum (Hong Kong, China)·2026

Narrative review: locally advanced thymoma-do we really need induction therapy before extended resection?

Mediastinum (Hong Kong, China)·2026

Invasive thymoma with rapid response to cisplatin, doxorubicin and cyclophosphamide (PAC) chemotherapy, after an early postoperative recurrence-a case report.

Mediastinum (Hong Kong, China)·2026

Related Experiment Videos

Incidence of rash and discontinuation of nevirapine using two different escalating initial doses

Related Concept Videos

[Incorporation of patient-reported outcomes into pharmacy and dermatology departments, in psoriasis and atopic dermatitis patients, as a tool to improve the healthcare quality and health outcomes].

[Help tools for the safe treatment of Ebola in emergency departments].

Treatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis.

Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients.

Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance.

Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes.

Retention in care: is it still a clinically useful indicator for monitoring long-term engagement in HIV care in the treat-all era?

Cancer incidence and risk factors among people with HIV in REPRIEVE.

Effects of semaglutide on subclinical cardiovascular health in people with HIV.

Antiretroviral therapy regimens initiated during pregnancy and risks of adverse perinatal outcomes.

Does where you live matter? Rurality and 30-day hospital readmission among people with HIV.

Circulating markers of organ damage associate with COPD in people with HIV: an exploratory proteomic analysis.

Confounding by indication in the evaluation of neoadjuvant chemotherapy: a sequential Cox analysis of an eight-year single-centre breast cancer cohort.

Trehalose Exerts Selective Cytotoxicity Against Tongue Squamous Cell Carcinoma Cells While Exhibiting Limited Cytotoxicity Toward Normal Oral Squamous Cells.

Pathological Complete Response following Pembrolizumab Combined with Gemcitabine and Cisplatin Therapy for Initially Unresectable Intrahepatic Cholangiocarcinoma: A Case Report.

Anti-angiogenic therapy in thymic carcinoma: a narrative review of current evidence and emerging combinations.

Narrative review: locally advanced thymoma-do we really need induction therapy before extended resection?

Invasive thymoma with rapid response to cisplatin, doxorubicin and cyclophosphamide (PAC) chemotherapy, after an early postoperative recurrence-a case report.

Related Experiment Videos

Incidence of rash and discontinuation of nevirapine using two different escalating initial doses

Related Concept Videos

Related Articles